Seòmar agus comataidhean

The SPCB’s approach to partnerships and accreditations is governed by our Diversity and Inclusion commitments and aims. The SPCB assesses accreditations having regard to issues such as budget and resource implications (including staff time to achieve the accreditation), alignment with the SPCB’s purpose and values, and the extent to which the accreditation supports the delivery of strategic aims and alignment with our policies, practices and procedures. While the SPCB does not intend to apply for Period Positive Workplace certification at this time, the SPCB is confident, having reviewed the Period Positive Workplace implementation plan, that it already has arrangements in place which are recognised as best practice for an inclusive, period positive workplace. This includes providing free period products in all toilets within Holyrood, a Period and Menopause policy and guidance for managers in supporting their staff. In order to ensure that this continues to be the case, the SPCB is committed to reviewing its Period and Menopause Policy so that it continues to meet the needs of its staff.

Progress with investment plans is included in my regular discussions with the Scottish Rail Holdings Group of companies and I met with ScotRail representatives on 27 February 2025. Transport Scotland officials meet regularly with ScotRail, Caledonian Sleeper and Scottish Rail Holdings to discuss any plans to replace existing rolling stock.

As set out in my answer to question S6W-32625 on 8 January 2025, Tier 3 and Tier 4 services are those secondary and specialist mental health services - including Community Mental Health Teams, Adult Acute Psychiatry, and specialist Perinatal Mental Health care, that usually require a referral from a GP or other health care professional. Data on this is not collected centrally by government. Decisions on access to those services are determined locally by NHS Boards.

To ensure access, we have directly allocated £123 million to NHS Boards and IJBs for a new Enhanced Mental Health Outcomes Framework in 2024-25. The Framework focuses on embedding increased capacity around CAMHS (Child and Adolescent Mental Health Services), the delivery of psychological therapies, eating disorder care, primary care and neurodevelopmental services, as well as ongoing innovation and service reform - but also brings together a number of other funding streams which includes Perinatal and Infant Mental Health.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Improving access to Mental Health services is a priority for Scottish Government and whilst we recognise the ongoing pressures facing the NHS, we remain committed to supporting all Boards to achieve the standard that 90% of patents start treatment within 18 weeks of referral in CAMHS and PT.

As was announced last week we have seen transformational improvements in CAMHS waiting lists over the last year and this has continued during the latest quarter. For the first time ever, national performance against the 18-week CAMHS standard has been met, with 90.6% of children and young people starting treatment within 18 weeks of referral in the last quarter and 1 in 2 children referred to CAMHS start treatment within 4 weeks compared to 12 weeks pre-pandemic (quarter ending March 2019).

Latest publication of data (4 March 2025) shows Psychological Therapies (PT) services are responding well to demand, with one in two people referred starting treatment within three weeks of referral.

More detailed information, including breakdowns at NHS Board level, can be found on the Public Health Scotland website where the latest publication on both PT and CAMHS waiting time is available for quarter ending December 2024 published on 4 March 2025. Publications - Public Health Scotland

I met with the former Parliamentary Under-Secretary of State for Public Health and Prevention on 04 November 2024 to discuss the Tobacco and Vapes Bill where I reaffirmed my support for this historic piece of legislation and highlighted how it could positively impact health inequalities in Scotland.

The Bill’s subsequent re-introduction on 5 November 2024 followed close collaborative work across the four nations over the content of the Bill. Officials across the four nations continue meet regularly to discuss the Bill to ensure coherence and alignment of policies, where this is possible and appropriate.

The Bill will gradually increase the age of sale for tobacco products and provide powers to legislate on vape flavours, displays, packaging, as well introduce an advertising ban for vapes and nicotine products. This will create a generational change, meaning that children born after 1 January 2009 will never legally be able to buy tobacco. This landmark legislation will ban vapes and nicotine products from being deliberately promoted and advertised to children to stop the next generation from becoming hooked on nicotine.

On 21 November 2024 a Legislative Consent Memorandum was introduced for consideration by the Scottish Parliament and I provided evidence to the Health, Social Care and Sport Committee on the Memorandum on 17 December 2024. I await the report from the Committee, and will then update Members and Committee on the next steps.

The Scottish Government encourages anyone to contact their GP or diabetes clinical team to discuss the use of Ozempic or any other medication as part of their treatment for type 2 diabetes. They will be best placed to recommend any medicines or treatments based on their own individual circumstances.

The Chief Pharmaceutical Officer is taking the issue of illegal online medicines seriously. She has met with the Medicines and Healthcare products Regulatory Agency (MHRA), Healthcare Improvement Scotland (HIS), Police Scotland and the General Pharmaceutical Council (GPhC) to discuss this.

The GPhC published updated guidance on 4 February 2025 regarding buying medicines safely online and Healthcare Improvement Scotland is considering how to improve the general awareness of these medicines, as well as establishing clear expectations for their safe and appropriate use within the independent healthcare sector.

The Chief Pharmaceutical Officer is also considering communications for healthcare professionals in Scotland on how to report known or suspected illicit prescribing of Ozempic.

The Scottish Government has not had specific discussions with North Lanarkshire, South Lanarkshire or Falkirk Council about underage vaping, including the sale of vapes to young people.

We work closely with the Society of Chief Officers of Trading Standards in Scotland (SCOTSS) on underage sales of vapes. SCOTSS provides an overview of the action taken at a local level on underage sales of vapes and provides an opportunity for concerns to be raised.

As members of the COSLA Trading Standards Policy and Co-ordination Group we are able to work with a range of stakeholders at national and local level on the topic of youth vaping.

This Government’s commitment to net zero by 2045 is absolutely unwavering. We await the advice of the Climate Change Committee on new Carbon Budget levels, expected on 21 May 2025. Once we have received this advice, we will bring forward the Scottish Carbon Emission Targets via secondary legislation, with the aim of publishing a draft Climate Change Plan to achieve those targets in the autumn, which will set a deliverable course towards net zero. The analysis undertaken by the Ricardo study, which was published on the Scottish Government Website in 2024, was only based on the information at that time on delivery of policies in the Climate Change Plan update which covers the period up to 2032. Further policies are currently under development for the next Climate Change Plan which will cover the period up to 2040 and the draft for consultation will include information on costs and benefits of the policies.

The data for the number of people being prescribed Ozempic by year in Scotland can be found in the following table.

To note: the table contains prescribing data for Ozempic only and does not include data for those being prescribed other branded semaglutide medicines.

The Scottish Government committed through the Programme for Government 2023 – 24, published on 5 September 2023, to improving miscarriage care, including the provision of separate private spaces in hospitals with maternity wards for women experiencing pregnancy and baby loss.

The Delivery Framework for Miscarriage Care, published on 6 February 2025, sets out that those experiencing miscarriage at any stage of pregnancy should be seen in a separate private space appropriate for bereavement. This action carries a priority category of “N” which means this should be implemented within 6 months from 1 April 2025.